Published in Eur J Endocrinol on March 05, 2010
Diagnostic Difficulties in a Pediatric Insulinoma: A Case Report. Medicine (Baltimore) (2016) 0.85
Vague neuroglycopenic complaints camouflage diagnosis of adolescent insulinoma: a case report. Int J Pediatr Endocrinol (2016) 0.83
Insulinoma: only in adults?-case reports and literature review. Eur J Pediatr (2013) 0.79
Arterial Calcium Stimulation with Hepatic Venous Sampling in the Localization Diagnosis of Endogenous Hyperinsulinism. Int J Endocrinol (2016) 0.75
Intra-arterial calcium stimulation test with hepatic venous sampling for preoperative diagnosis of a large insulinoma in an obese young man. Singapore Med J (2014) 0.75
Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management. Endocr Connect (2017) 0.75
Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet (2002) 16.29
Cushing's syndrome. Lancet (2006) 5.19
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2008) 4.68
An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet (2006) 4.56
Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet (2011) 3.97
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab (2002) 3.43
Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab (2007) 3.25
AIP mutation in pituitary adenomas in the 18th century and today. N Engl J Med (2011) 3.14
The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev (2004) 2.88
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab (2005) 2.80
Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat (2010) 2.75
The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer (2007) 2.10
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. Eur Urol (2011) 1.93
Ghrelin--a hormone with multiple functions. Front Neuroendocrinol (2004) 1.88
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem (2005) 1.83
Clinical review: Diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab (2005) 1.79
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf) (2008) 1.78
Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review. Eur J Endocrinol (2012) 1.73
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol (1989) 1.72
Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? Br J Radiol (2002) 1.71
Magnetic resonance imaging of fistula-in-ano. Dis Colon Rectum (1994) 1.68
Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol (2008) 1.68
Overall and cause-specific mortality in GH-deficient adults on GH replacement. Eur J Endocrinol (2012) 1.62
The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metab (2003) 1.61
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab (2003) 1.60
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol (2000) 1.55
Renal function after high dose urography in patients with renal failure. Br J Radiol (1981) 1.52
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer. Clin Cancer Res (2011) 1.51
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf) (2007) 1.50
90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol (2010) 1.49
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One (2008) 1.49
Centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma. AJR Am J Roentgenol (2012) 1.48
Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment. J Clin Endocrinol Metab (2003) 1.47
Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics (2009) 1.43
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab (2008) 1.42
An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor. Endocrinology (2002) 1.42
Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency. Eur J Endocrinol (2007) 1.42
Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas. Clin Endocrinol (Oxf) (2013) 1.39
Outcome scoring in neurosurgery: the cognitive outcome score, an alternative to the Glasgow outcome scale. J Clin Neurosci (2005) 1.39
Pseudotumor cerebri syndrome: venous sinus obstruction and its treatment with stent placement. J Neurosurg (2003) 1.37
Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol (2007) 1.33
Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers. Clin Endocrinol (Oxf) (2008) 1.32
Rathke's cleft cysts. Clin Endocrinol (Oxf) (2012) 1.32
CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas). Eur Radiol (2004) 1.29
Expanding role of AMPK in endocrinology. Trends Endocrinol Metab (2006) 1.29
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol (2003) 1.26
Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer (2010) 1.26
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer (1998) 1.26
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms. Endocr Relat Cancer (2008) 1.25
The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol (2010) 1.23
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas. JAMA (2010) 1.22
Renal involvement in patients with non-Hodgkin's lymphoma: clinical and pathological features in 23 cases. Hematol Oncol (1990) 1.21
The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer (2007) 1.19
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator. Immunol Cell Biol (2003) 1.19
Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease. Pituitary (2005) 1.18
The ectopic ACTH syndrome. Rev Endocr Metab Disord (2010) 1.18
Magnetic resonance imaging of anal fistulae. Lancet (1992) 1.17
CT appearances of desmoid tumours in familial adenomatous polyposis: further observations. Clin Radiol (1994) 1.15
Embryology of the adrenal glands and its relevance to diagnostic imaging. Clin Radiol (2005) 1.15
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clin Endocrinol (Oxf) (2008) 1.15
Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia. Am J Respir Crit Care Med (2007) 1.15
Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas. Ann Intern Med (2013) 1.15
Work-up and management of paediatric Cushing's syndrome. Curr Opin Endocrinol Diabetes Obes (2008) 1.15
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation. Neuroendocrinology (2009) 1.15
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol (Oxf) (2003) 1.14
The peritoneum, mesenteries and omenta: normal anatomy and pathological processes. Eur Radiol (1998) 1.14
Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome. Eur J Endocrinol (2003) 1.13
Fibrosis and carcinoid syndrome: from causation to future therapy. Nat Rev Endocrinol (2009) 1.12
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line. Neuroendocrinology (2007) 1.11
The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab (2006) 1.11
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB J (2008) 1.11
The pre-operative assessment of advanced gastric cancer by computed tomography. Br J Surg (1984) 1.11
Lymphoma of the spleen. Semin Ultrasound CT MR (2007) 1.10
Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry (1997) 1.10
Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours. Endocr Relat Cancer (2009) 1.09